(Q39953010)

15 September 2017

title

Shedding of epidermal growth factor receptor is a regulated process that occurs with overexpression in malignant cells (English)

1 reference

15 September 2017

1 reference

Marianela Perez-Torres

1

1 reference

15 September 2017

Blanca L Valle

2

1 reference

15 September 2017

Nita J Maihle

3

1 reference

15 September 2017

Lisandra Negron-Vega

4

1 reference

15 September 2017

Rene Nieves-Alicea

5

1 reference

15 September 2017

Elsa M Cora

6

1 reference

15 September 2017

language of work or name

English

0 references

publication date

25 July 2008

1 reference

Experimental Cell Research

15 September 2017

published in

1 reference

15 September 2017

volume

314

1 reference

15 September 2017

issue

16

1 reference

15 September 2017

page(s)

2907-2918

1 reference

Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

EGF receptor expression, regulation, and function in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

A 1.8 kb alternative transcript from the human epidermal growth factor receptor gene encodes a truncated form of the receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Isolation and characterization of four alternate c-erbB3 transcripts expressed in ovarian carcinoma-derived cell lines and normal human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Diverse cell surface protein ectodomains are shed by a system sensitive to metalloprotease inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Protein ectodomain shedding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Soluble receptors for cytokines and growth factors: generation and biological function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Cleavage of the membrane precursor for transforming growth factor alpha is a regulated process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Tyrosine phosphorylation and proteolysis. Pervanadate-induced, metalloprotease-dependent cleavage of the ErbB-4 receptor and amphiregulin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Identification of serum factor inducing ectodomain shedding of proHB-EGF and sStudies of noncleavable mutants of proHB-EGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

An essential role for ectodomain shedding in mammalian development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Matrix metalloproteinases: they're not just for matrix anymore!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

The ADAMs family of metalloproteases: multidomain proteins with multiple functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Tumor necrosis factor-alpha-converting enzyme is required for cleavage of erbB4/HER4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Identification of ADAM10 as a major source of HER2 ectodomain sheddase activity in HER2 overexpressing breast cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Characterization of Glycosylation Sites of the Epidermal Growth Factor Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Production of an Epidermal Growth Factor Receptor-Related Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

A sandwich type acridinium-linked immunosorbent assay (ALISA) detects soluble ErbB1 (sErbB1) in normal human sera

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Monoclonal antibodies specific for peptide epitopes of the epidermal growth factor receptor's extracellular domain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Generation and characterization of polyclonal antibodies specific for human p110 sEGFR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

The cytoplasmic carboxy-terminal amino acid specifies cleavage of membrane TGF alpha into soluble growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Membrane-anchored growth factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Cell surface localization of proteolysis of human endothelial angiotensin I-converting enzyme. Effect of the amino-terminal domain in the solubilization process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

EGF-induced programmed cell death of human mammary carcinoma MDA-MB-468 cells is preceded by activation AP-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Properties of pervanadate and permolybdate. Connexin43, phosphatase inhibition, and thiol reactivity as model systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

ADAMs: key components in EGFR signalling and development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Metalloprotease-dependent protransforming growth factor-alpha ectodomain shedding in the absence of tumor necrosis factor-alpha-converting enzyme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Metalloproteinase inhibitors: biological actions and therapeutic opportunities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Regulated intracellular ligand transport and proteolysis control EGF signal activation in Drosophila

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Drosophila rhomboid-1 defines a family of putative intramembrane serine proteases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Proteolysis within the membrane: rhomboids revealed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Intramembrane cleavage of ephrinB3 by the human rhomboid family protease, RHBDL2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Mechanism of intramembrane proteolysis investigated with purified rhomboid proteases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Substrate specificity of rhomboid intramembrane proteases is governed by helix-breaking residues in the substrate transmembrane domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Linear non-competitive inhibition of solubilized human gamma-secretase by pepstatin A methylester, L685458, sulfonamides, and benzodiazepines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Progressive abrogation of TGF-beta 1 and EGF growth control is associated with tumour progression in ras-transfected human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

EGFR family-mediated signal transduction in the human keratinocyte cell line HaCaT.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Epidermal growth factor receptor transmembrane domain: 2H NMR implications for orientation and motion in a bilayer environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Conformation of the transmembrane domain of the epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

The shedding of membrane-anchored heparin-binding epidermal-like growth factor is regulated by the Raf/mitogen-activated protein kinase cascade and by cell adhesion and spreading

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Endocytosis-independent mechanisms of Delta ligand proteolysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Identification of a novel AU-Rich element in the 3' untranslated region of epidermal growth factor receptor mRNA that is the target for regulated RNA-binding proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Overexpression of epidermal growth factor receptor in human head and neck squamous carcinoma cell lines correlates with matrix metalloproteinase-9 expression and in vitro invasion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

Biologic effects of heregulin/neu differentiation factor on normal and malignant human breast and ovarian epithelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2008.07.013

10.1016/J.YEXCR.2008.07.013

7 January 2021

Identifiers

DOI

1 reference

15 September 2017

1 reference